table of content
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmacokinetics Services
1.2 Key Market Segments
1.2.1 Pharmacokinetics Services Segment by Type
1.2.2 Pharmacokinetics Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmacokinetics Services Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmacokinetics Services Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmacokinetics Services Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmacokinetics Services Market Competitive Landscape
3.1 Global Pharmacokinetics Services Sales by Manufacturers (2019-2024)
3.2 Global Pharmacokinetics Services Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacokinetics Services Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmacokinetics Services Sales Sites, Area Served, Product Type
3.6 Pharmacokinetics Services Market Competitive Situation and Trends
3.6.1 Pharmacokinetics Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacokinetics Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmacokinetics Services Industry Chain Analysis
4.1 Pharmacokinetics Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmacokinetics Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmacokinetics Services Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacokinetics Services Sales Market Share by Type (2019-2024)
6.3 Global Pharmacokinetics Services Market Size Market Share by Type (2019-2024)
6.4 Global Pharmacokinetics Services Price by Type (2019-2024)
7 Pharmacokinetics Services Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacokinetics Services Market Sales by Application (2019-2024)
7.3 Global Pharmacokinetics Services Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmacokinetics Services Sales Growth Rate by Application (2019-2024)
8 Pharmacokinetics Services Market Segmentation by Region
8.1 Global Pharmacokinetics Services Sales by Region
8.1.1 Global Pharmacokinetics Services Sales by Region
8.1.2 Global Pharmacokinetics Services Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacokinetics Services Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacokinetics Services Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacokinetics Services Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacokinetics Services Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacokinetics Services Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Evotec AG (Germany)
9.1.1 Evotec AG (Germany) Pharmacokinetics Services Basic Information
9.1.2 Evotec AG (Germany) Pharmacokinetics Services Product Overview
9.1.3 Evotec AG (Germany) Pharmacokinetics Services Product Market Performance
9.1.4 Evotec AG (Germany) Business Overview
9.1.5 Evotec AG (Germany) Pharmacokinetics Services SWOT Analysis
9.1.6 Evotec AG (Germany) Recent Developments
9.2 Pacific BioLabs (US)
9.2.1 Pacific BioLabs (US) Pharmacokinetics Services Basic Information
9.2.2 Pacific BioLabs (US) Pharmacokinetics Services Product Overview
9.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product Market Performance
9.2.4 Pacific BioLabs (US) Business Overview
9.2.5 Pacific BioLabs (US) Pharmacokinetics Services SWOT Analysis
9.2.6 Pacific BioLabs (US) Recent Developments
9.3 GVK Biosciences Private Limited (India)
9.3.1 GVK Biosciences Private Limited (India) Pharmacokinetics Services Basic Information
9.3.2 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Overview
9.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Market Performance
9.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services SWOT Analysis
9.3.5 GVK Biosciences Private Limited (India) Business Overview
9.3.6 GVK Biosciences Private Limited (India) Recent Developments
9.4 Shanghai Medicilon Inc. (China)
9.4.1 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Basic Information
9.4.2 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Overview
9.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Market Performance
9.4.4 Shanghai Medicilon Inc. (China) Business Overview
9.4.5 Shanghai Medicilon Inc. (China) Recent Developments
9.5 Pharmaceutical Product Development, LLC (US)
9.5.1 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Basic Information
9.5.2 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Overview
9.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Market Performance
9.5.4 Pharmaceutical Product Development, LLC (US) Business Overview
9.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments
9.6 Charles River Laboratories International, Inc. (US)
9.6.1 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Basic Information
9.6.2 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Overview
9.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Market Performance
9.6.4 Charles River Laboratories International, Inc. (US) Business Overview
9.6.5 Charles River Laboratories International, Inc. (US) Recent Developments
9.7 PAREXEL International Corporation (US)
9.7.1 PAREXEL International Corporation (US) Pharmacokinetics Services Basic Information
9.7.2 PAREXEL International Corporation (US) Pharmacokinetics Services Product Overview
9.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product Market Performance
9.7.4 PAREXEL International Corporation (US) Business Overview
9.7.5 PAREXEL International Corporation (US) Recent Developments
9.8 Eurofins Scientific, Inc. (Luxembourg)
9.8.1 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Basic Information
9.8.2 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Overview
9.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Market Performance
9.8.4 Eurofins Scientific, Inc. (Luxembourg) Business Overview
9.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments
9.9 Frontage Labs (US)
9.9.1 Frontage Labs (US) Pharmacokinetics Services Basic Information
9.9.2 Frontage Labs (US) Pharmacokinetics Services Product Overview
9.9.3 Frontage Labs (US) Pharmacokinetics Services Product Market Performance
9.9.4 Frontage Labs (US) Business Overview
9.9.5 Frontage Labs (US) Recent Developments
9.10 SGS SA (Switzerland)
9.10.1 SGS SA (Switzerland) Pharmacokinetics Services Basic Information
9.10.2 SGS SA (Switzerland) Pharmacokinetics Services Product Overview
9.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product Market Performance
9.10.4 SGS SA (Switzerland) Business Overview
9.10.5 SGS SA (Switzerland) Recent Developments
9.11 LGC Limited (UK)
9.11.1 LGC Limited (UK) Pharmacokinetics Services Basic Information
9.11.2 LGC Limited (UK) Pharmacokinetics Services Product Overview
9.11.3 LGC Limited (UK) Pharmacokinetics Services Product Market Performance
9.11.4 LGC Limited (UK) Business Overview
9.11.5 LGC Limited (UK) Recent Developments
9.12 Creative Bioarray (US)
9.12.1 Creative Bioarray (US) Pharmacokinetics Services Basic Information
9.12.2 Creative Bioarray (US) Pharmacokinetics Services Product Overview
9.12.3 Creative Bioarray (US) Pharmacokinetics Services Product Market Performance
9.12.4 Creative Bioarray (US) Business Overview
9.12.5 Creative Bioarray (US) Recent Developments
9.13 Certara, L.P. (Germany)
9.13.1 Certara, L.P. (Germany) Pharmacokinetics Services Basic Information
9.13.2 Certara, L.P. (Germany) Pharmacokinetics Services Product Overview
9.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product Market Performance
9.13.4 Certara, L.P. (Germany) Business Overview
9.13.5 Certara, L.P. (Germany) Recent Developments
10 Pharmacokinetics Services Market Forecast by Region
10.1 Global Pharmacokinetics Services Market Size Forecast
10.2 Global Pharmacokinetics Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacokinetics Services Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacokinetics Services Market Size Forecast by Region
10.2.4 South America Pharmacokinetics Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacokinetics Services by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmacokinetics Services Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmacokinetics Services by Type (2025-2030)
11.1.2 Global Pharmacokinetics Services Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmacokinetics Services by Type (2025-2030)
11.2 Global Pharmacokinetics Services Market Forecast by Application (2025-2030)
11.2.1 Global Pharmacokinetics Services Sales (K Units) Forecast by Application
11.2.2 Global Pharmacokinetics Services Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
